Cardiovascular ACE2 receptor expression in patients undergoing heart transplantation

Cardiovascular ACE2 receptor expression in patients undergoing heart transplantation

Abstract Aims Membrane‐bound angiotensin‐converting enzyme (ACE)2 is the main cellular access point for SARS‐CoV‐2, but its expression and the effect of ACE inhibition have not been assessed quantitatively in patients with heart failure. The aim of this study was to characterize membrane‐bound ACE2...

Full description

Bibliographic Details
Main Authors: Johannes Bargehr, Patrick Rericha, Alex Petchey, Maria Colzani, Georgia Moule, Marie Chet Malgapo, Doris Rassl, Jason Tarkin, Greg Mellor, Fotis Sampaziotis, Teresa Brevini, Laure Gambardella, Martin R. Bennett, Sanjay Sinha
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:ESC Heart Failure
Subjects:
COVID‐19; SARS‐CoV‐2; Heart failure; Heart transplantation; ACE inhibitor
Online Access:https://doi.org/10.1002/ehf2.13528

Internet

https://doi.org/10.1002/ehf2.13528

Similar Items